In terms of capitalization, the global microcrystalline cellulose market is estimated to enroll itself in the billion-dollar business fraternity by 2024. The ongoing expansion of the pharmaceutical domain undoubtedly is one of the pivotal forces driving the overall industry size, as the product is extensively utilized as an excipient in drug formulation. Ever since its inception, microcrystalline cellulose has made its presence felt in the pharma domain as an extremely important tableting agent pertaining to its compressibility properties. Reportedly, the product’s small bulk density and flow characteristics make it suitable for any kind of oral dosage.
Sample copy of this report @
It is imperative to mention that the extensive research investments in the pharma space over the recent years has undoubtedly widened the application scope of microcrystalline cellulose market. As per reliable estimates, global pharmaceutical industry spent more than USD 150 billion on research and development in the year 2016, a spike of almost USD 25 billion from what it recorded in 2008. It has also been speculated that the figure is likely to shoot up to almost USD 180 billion over the coming four years, another data backing microcrystalline cellulose market’s lucrative growth prospects from pharmaceutical sector.Speaking along similar lines, North America stands as one of the major beneficiaries of the increased pharmaceutical spending trend, with the United States as the chief revenue pocket. According to International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), overall R&D investments pertaining to pharmaceutical sector was more than USD 60 billion in 2016.
Make an inquiry for purchasing this report @
Elaborating further on the regional trends, the expanding obese population in the country is also substantially fueling the regional mcc demand. As per a latest projection by Organization for Economic Co-operation and Development (OECD), nearly 75% of the American population is likely to be obese or overweight by the end of 2020.
As per CDC’s estimation (as of 2014) – around one third of U.S. adults of age group 20 and more, and 17% of adolescents and children were marred obese. Backed by the clinical studies that validate the role of insoluble dietary fibers in maintaining the body weight and other obesity induced disorders, North America microcrystalline cellulose industry is presumed to record a CAGR of 5.5% over 2017-2024.
The competitive spectrum of microcrystalline cellulose market is famed to be quite consolidated, with renowned firms like Asahi Kasei, FMC Corporation, and Mingtai Chemical covering half of the global share. The consolidation, in recent years, has been rather strengthened with companies feverishly inclining toward distribution network enhancement and production capacity expansion. Citing a relevant testimony to the declaration would be DFE Pharma GmbH & Co’s opening of a new MCC manufacturing facility in India couple of years back.
Browse Report Summery @
Sigachi Industrial, another leading name in microcrystalline cellulose market, started working on a new microcrystalline cellulose production plant in Dahej, Gujarat in the year 2013. Some of the pivotal firms are also undertaking mergers & acquisitions activities in a bid to extend their product portfolio. Say for instance, Mingtai Chemical Co. made it to the front page few years back, announcing the extension of its agreement with Danisco (DuPont Nutrition & Health) for the manufacturing of colloidal grade microcrystalline cellulose. These aforementioned instances depict only a fraction of the ongoing developments underlining microcrystalline cellulose industry space.
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.